Dr. McLaughlin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5901 W Memorial Rd
Oklahoma City, OK 73142Phone+1 405-422-9688
Education & Training
- University of Texas Southwestern Medical CenterResidency, Radiation Oncology, 2018 - 2022
- Baylor College of MedicineClass of 2017
Certifications & Licensure
- OK State Medical License 2022 - 2025
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 25 citationsPhase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer.Raquibul Hannan, Mark F McLaughlin, Laurentiu M Pop, Ivan Pedrosa, Payal Kapur
European Urology. 2023-09-01 - 45 citations5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International ...Shankar Siva, Muhammad Ali, Rohann J M Correa, Alexander Muacevic, Lee Ponsky
The Lancet. Oncology. 2022-12-01 - 22 citationsStereotactic ablative radiation therapy for renal cell carcinoma with inferior vena cava tumor thrombus.Yuval Freifeld, Ivan Pedrosa, Mark Mclaughlin, Rohann M Correa, Alexander V Louie
Urologic Oncology. 2022-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: